Bcl-2 constitutively suppresses p53-dependent apoptosis in colorectal cancer cells

被引:131
作者
Jiang, M [1 ]
Milner, J [1 ]
机构
[1] Univ York, Dept Biol, Yorkshire Canc Res Lab P53, York YO10 5DD, N Yorkshire, England
关键词
p53; Bcl-2; Bcl-x(L); Bax; colorectal cancer; apoptosis;
D O I
10.1101/gad.252603
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
To dissect apoptotic genes governing the survival of colorectal carcinoma cells, we employed RNAi to silence Bcl-2 and Bcl-X-L in isogenic clones of p53+/+ and p53-/-cells, and of Bax+/- and Bax-/- cells. We identify a novel proapoptotic function of p53 that does not require activation by genotoxic agents and that appears to be constitutively suppressed by Bcl-2. Silencing of Bcl-2 induced massive p53-dependent apoptosis. The "Bcl-2/p53 axis" requires Bax and caspase 2 as essential apoptotic mediators. This newly discovered Bcl-2/p53 functional interface represents a key regulator of apoptosis which can be activated by targeting Bcl-2 in colorectal carcinoma cells.
引用
收藏
页码:832 / 837
页数:6
相关论文
共 20 条
[1]   BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH [J].
BOISE, LH ;
GONZALEZGARCIA, M ;
POSTEMA, CE ;
DING, LY ;
LINDSTEN, T ;
TURKA, LA ;
MAO, XH ;
NUNEZ, G ;
THOMPSON, CB .
CELL, 1993, 74 (04) :597-608
[2]  
BRANCH P, 1995, CANCER RES, V55, P2304
[3]   Disruption of p53 in human cancer cells alters the responses to therapeutic agents [J].
Bunz, F ;
Hwang, PM ;
Torrance, C ;
Waldman, T ;
Zhang, YG ;
Dillehay, L ;
Williams, J ;
Lengauer, C ;
Kinzler, KW ;
Vogelstein, B .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (03) :263-269
[4]   The BCL2 family: Regulators of the cellular life-or-death switch [J].
Cory, S ;
Adams, JM .
NATURE REVIEWS CANCER, 2002, 2 (09) :647-656
[5]   Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells [J].
Elbashir, SM ;
Harborth, J ;
Lendeckel, W ;
Yalcin, A ;
Weber, K ;
Tuschl, T .
NATURE, 2001, 411 (6836) :494-498
[6]   PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs [J].
He, TC ;
Chan, TA ;
Vogelstein, B ;
Kinzler, KW .
CELL, 1999, 99 (03) :335-345
[7]   Tumor regression by targeted gene delivery to the neovasculature [J].
Hood, JD ;
Bednarski, M ;
Frausto, R ;
Guccione, S ;
Reisfeld, RA ;
Xiang, R ;
Cheresh, DA .
SCIENCE, 2002, 296 (5577) :2404-2407
[8]   Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution [J].
Ionov, Y ;
Yamamoto, H ;
Krajewski, S ;
Reed, JC ;
Perucho, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (20) :10872-10877
[9]   UBIQUITOUS SOMATIC MUTATIONS IN SIMPLE REPEATED SEQUENCES REVEAL A NEW MECHANISM FOR COLONIC CARCINOGENESIS [J].
IONOV, Y ;
PEINADO, MA ;
MALKHOSYAN, S ;
SHIBATA, D ;
PERUCHO, M .
NATURE, 1993, 363 (6429) :558-561
[10]   Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference [J].
Jiang, M ;
Milner, J .
ONCOGENE, 2002, 21 (39) :6041-6048